Zobrazeno 1 - 10
of 139
pro vyhledávání: '"Giriraj T. Kulkarni"'
Publikováno v:
Frontiers in Chemistry, Vol 9 (2021)
Hydrogels possess a unique three-dimensional, cross-linked network of polymers capable of absorbing large amounts of water and biological fluids without dissolving. Nanohydrogels (NGs) or nanogels are composed of diverse types of polymers of syntheti
Externí odkaz:
https://doaj.org/article/fc222e75ff0d4adc98946c54ed5688e2
Publikováno v:
Basic and Clinical Neuroscience Journal. 14:247-262
Introduction: A neurodevelopmental disorder, autism is typically identified with three primary behavioral consequences, such as social impairment, communication problems, and limited or stereotypical behavior. Because of its co-morbidity and lack of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e75e9916dfa2a27e2b7a93c55acc610a
https://doi.org/10.32598/bcn.2021.2966.1
https://doi.org/10.32598/bcn.2021.2966.1
Publikováno v:
Frontiers in Chemistry, Vol 9 (2021)
Nanotechnology has made a great impact on the pharmaceutical, biotechnology, food, and cosmetics industries. More than 40% of the approved drugs are lipophilic and have poor solubility. This is the major rate-limiting step that influences the release
Externí odkaz:
https://doaj.org/article/7ec851dbcf7646baa557824e3eee6b57
Publikováno v:
Recent Patents on Nanotechnology. 17:15-17
Background: The novel coronavirus 2019 (COVID-19) infection has caused the global emergence of coronavirus in humans during the last 12 months. Till May 11, 2021, the confirmed global COVID-19 cases and deaths reached 158551526 and 3296855, respectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bb088aa86de70bd8d5308d30b6dea18
https://doi.org/10.2174/1872210515666210720130736
https://doi.org/10.2174/1872210515666210720130736
Publikováno v:
Research Journal of Pharmacy and Technology. :4218-4225
Raloxifene (RLX) and Curcumin (CUR) are used for the treatment of breast cancer. Its combination is chosen because of their synergistic therapeutic potential, which helps to reduce drug-related toxicities while increasing therapeutic efficacy. A simp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02cb60533567d46ea15e93527bbe39d2
https://doi.org/10.52711/0974-360x.2022.00709
https://doi.org/10.52711/0974-360x.2022.00709
Publikováno v:
International Journal of Pharmacy and Pharmaceutical Sciences. :44-50
Objective: The aim of the present study was to assess bioactive compounds found in Tulsi as potential COVID-19 Mpr °inhibitor using molecular docking and to provide scientific justification in term of its active ingredient to target protein for prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7005acef3f35e714400bdfee8cc4ea5f
https://doi.org/10.22159/ijpps.2022v14i4.43181
https://doi.org/10.22159/ijpps.2022v14i4.43181
Publikováno v:
Journal of Ethnopharmacology. 315:116685
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18c9e521a0e039adcdb5d097fe5cbbdc
https://doi.org/10.1016/j.jep.2023.116685
https://doi.org/10.1016/j.jep.2023.116685
Publikováno v:
Journal of Research in Pharmacy. 26:1092-1104
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b31ccdb4e93b61950dd78ae6deb0e5de
https://doi.org/10.29228/jrp.105
https://doi.org/10.29228/jrp.105
Publikováno v:
Journal of Pharmaceutical Research International. :117-137
The aim of this work is to study the anti-proliferative potential of two anticancer drugs loaded in nanostructured lipid carriers (NLCs).The maximal inhibition of cell growth by Raloxifene (RLX) & Curcumin (CUM) nanostructured lipid carriers (RLX-CUM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf75109377dcffbf12da70e626cbe774
https://doi.org/10.9734/jpri/2021/v33i53a33645
https://doi.org/10.9734/jpri/2021/v33i53a33645
Publikováno v:
Autism Research. 14:2270-2286
Autism spectrum disorder (ASD) is a neurodevelopmental disorder with complex etiology and phenotypes. Phosphodiesterase-1 (PDE1) inhibitors are known to provide benefits in various brain conditions manifesting similar behavioral phenotypes. The pharm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::624dd233bce40bef2868a3e19111812c
https://doi.org/10.1002/aur.2597
https://doi.org/10.1002/aur.2597